Sorrento Therapeutics Inc (SRNE) Stock: Is It a Good Pick?

Tuesday, September 29, 2020 10:46 AM | InvestorsObserver Analysts

Sorrento Therapeutics Inc (SRNE) stock has gained 412.15% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 78 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 92. SRNE's rank also includes a fundamental score of 85. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of 24. This means analysts expect the stock to climb 118.98% over the next 12 months. The short-term technical score for SRNE is 57.

Overall Score - 78
SRNE has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on SRNE!

What's Happening with SRNE Stock Today

Sorrento Therapeutics Inc (SRNE) stock is higher by 7.98% while the S&P 500 is unchanged 0% as of 10:45 AM on Tuesday, Sep 29. SRNE has gained $0.81 from the previous closing price of $10.15 on volume of 18,525,849 shares. Over the past year the S&P 500 is up 12.59% while SRNE has gained 412.15%. SRNE lost -$1.61 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Sorrento Therapeutics Inc (SRNE) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Sector Update: Biotech Stocks Help Drag Health Care Sector Lower

Sector Update: Health Care

How Will the Market React to Gamida Cell Ltd (GMDA) Stock Getting a Bullish Rating

Is OrganiGram Holdings Inc (OGI) Stock About to Get Hot Monday?

Related Companies